Man Group PLC G1 Therapeutics, Inc. Transaction History
Man Group PLC
- $37.6 Billion
- Q2 2024
A detailed history of Man Group PLC transactions in G1 Therapeutics, Inc. stock. As of the latest transaction made, Man Group PLC holds 127,723 shares of GTHX stock, worth $913,219. This represents 0.0% of its overall portfolio holdings.
Number of Shares
127,723
Previous 275,358
53.62%
Holding current value
$913,219
Previous $1.19 Million
75.53%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding GTHX
# of Institutions
54Shares Held
11MCall Options Held
1.85MPut Options Held
1.18M-
Black Rock Inc. New York, NY3.08MShares$22 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA1.36MShares$9.74 Million0.03% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY767KShares$5.48 Million0.0% of portfolio
-
Jacobs Levy Equity Management, Inc Florham Park, NJ464KShares$3.31 Million0.0% of portfolio
-
Tekla Capital Management LLC424KShares$3.03 Million0.04% of portfolio
About G1 Therapeutics, Inc.
- Ticker GTHX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,746,800
- Market Cap $306M
- Description
- G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...